Author: admin

  • ‘Slap on the wrist’: critics decry weak penalties on Google after landmark monopoly trial | Google

    ‘Slap on the wrist’: critics decry weak penalties on Google after landmark monopoly trial | Google

    A judge ruled on Tuesday that Google would not be forced to sell its Chrome browser or the Android operating system, saving the tech giant from the most severe penalties sought by the US government. The same judge had ruled in favor of US prosecutors nearly a year ago, finding that Google built and maintained an illegal monopoly with its namesake search engine.

    Groups critical of Google’s dominance in the internet search and online advertising industry are furious. They contend the judge missed an opportunity to enact meaningful change in an industry that has suffocated under the crushing weight of its heaviest player. Tech industry groups and investors, by contrast, are thrilled. Shares in Alphabet, Google’s parent company, have risen 9% since Tuesday afternoon.

    Judge Amit Mehta did order Google to share data from its search engine with its rivals. He also enjoined the company from entering or maintaining exclusive contracts relating to the distribution of its products including Chrome, Google Assistant and the Gemini app. That penalty will not, however, prevent it from paying distributors such as Apple and Mozilla, which use Google as the default search engine for their respective browsers. Google faces a separate hearing later this year on its monopoly over online advertising technology.

    The Department of Justice celebrated the ruling in a Tuesday press release that called Mehta’s proposed remedies “significant”.

    “The court’s ruling today recognizes the need for remedies that will pry open the market for general search services, which has been frozen in place for over a decade,” the announcement reads.

    It’s not enough, say free market advocates.

    Critics say judge handed Google a lenient win

    Mehta’s decision resulted in an immediate wave of backlash from big tech critics who have been closely following the antitrust case for years. Many of these thinktanks and advocacy groups had long called for Google to be broken up for its monopolistic tactics, arguing that forceful action was needed to restore meaningful competition.

    Instead of opening up the online search industry, however, critics of the ruling allege that it will now retrench Google’s dominance while setting a precedent that big tech need not fear serious consequences for breaking the law.

    “Google for years has wielded its vast power over all layers of the digital economy to crush competitors, halt innovation and rob Americans of their right to read, watch and buy what they want without being manipulated by one of the most powerful corporations in human history,” Barry Lynn, executive director at the Open Markets Institute thinktank, said. “Judge Mehta’s order that Google share search data with competitors and cease entering into exclusive contracts does nothing to right those wrongs. Instead, it lets Google and every other monopolist know that even the most egregious violation of law will be met with a slap on the wrist.”

    Some groups and experts took issue with how Mehta’s ruling that Google had illegally maintained a monopoly could result in the more lenient decision handed down this week.

    “You don’t find someone guilty of robbing a bank and then sentence him to writing a thank you note for the loot,” said Nidhi Hegde, executive director of the American Economic Liberties Project non-profit.

    Several tech leaders, including the CEOs of Yelp, search engine DuckDuckGo and Epic Games, additionally condemned the decision for failing to adequately level the playing field for competitors. Yelp and Epic Games have both sued Google over antitrust issues, while DuckDuckGo’s CEO testified in the government’s antitrust trial against the search giant.

    “It’s like a defendant robbed a series of banks and the court verdict found them guilty, then sentenced them to probation under which they may continue robbing banks but must share data on how they rob banks with competing bank robbers,” Tim Sweeney, CEO of Epic Games, posted on X in yet another use of a bank robbing analogy.

    Democratic lawmakers who have urged for stronger regulations on big tech similarly denounced the ruling, in some cases calling for the justice department to appeal the decision.

    “The court previously ruled that Google’s search business is an illegal monopoly, but now the judge’s remedies fail to hold Google accountable for breaking the law,” the Massachusetts senator Elizabeth Warren said in a statement. “Instead of restoring competition and ending Google’s dominance, this ruling is a slap on the wrist for unlawful behavior that warranted the breakup of this tech giant.”

    The chairs of the Monopoly Busters caucus – US representatives Chris Deluzio, Pramila Jayapal, Pat Ryan and Angie Craig – also issued a statement calling the decision a “slap on the wrist” and alleging it undermines bipartisan efforts to rein in tech monopolies.

    “In practice, this ruling allows Google to stay a monopoly. Despite finding Google guilty of search monopolization, the court is allowing the company to retain Chrome and Android, key tools that Google uses to dominate the market,” the caucus said.

    The decision also drew the ire of human rights group Amnesty International, which said that Google’s business model is built on pervasive surveillance” and that Chrome is an important tool used for harvesting the personal data of Google users.

    skip past newsletter promotion

    “Forcing Google to break up its search business and sell Chrome could have marked a first step toward a digital world that respects our rights,” said Agnès Callamard, secretary general of Amnesty International.

    Silicon Valley and Wall Street cheer

    While trustbusters lamented the ruling, the tech industry cheered. Industry groups weighed in saying Mehta’s decision avoided calamitous results for Silicon Valley. The Developers Alliance, a tech industry group, said it was pleased that the judge “rejected the draconian structural remedies” that the justice department had requested in the case.

    “Divesting Chrome and Android would have had disastrous consequences for web and app developers and the broader digital ecosystem,” the group said in a statement. “Developers are relieved that the political theater of this trial has ended.”

    Another industry group, the Consumer Choice Center, invoked Google’s arguments from the trial in which the search engine giant said it had the best product and that is why it dominates the market. Stephen Kent, the group’s media director, said the justice department’s “politicized case” held “larger players in contempt for having superior products that people freely use instead of rival apps and services”.

    Many of these groups cited Mehta’s argument that in the year or so since he originally ruled that Google’s search business was monopolistic, the burgeoning AI space has produced both financially and technologically viable competitors to Chrome for the first time in years. “These new realities give the court hope that Google will not simply outbid competitors for distribution if superior competitors emerge,” Mehta’s ruling read.

    “Arguing about search engine market share when dramatic and remarkable advances in AI were upending the industry was head-scratching at best,” the Developers Alliance said.

    Jennifer Huddleston, senior fellow at libertarian thinktank the Cato Institute, said the courts should proceed with caution and “recognize that innovation often remains our best competition policy” when attempting to rule on antitrust cases.

    “The months that have passed between the initial ruling and the remedies decision have shown how rapidly markets in the tech sector can change,” Hiddleston said in a statement. “This is particularly true in the present, given the disruptive nature of AI products in search. As Judge Mehta’s decision notes, such cases ask courts to predict the future of a rapidly changing market rather than merely look at historical facts, as it typically does, and that doing such is not a judge’s forte.”

    As Google’s stock bounced on the news of Mehta’s ruling, Apple also saw a boost. The iPhone maker historically received billions of dollars from Google annually to make Google Search the default engine on its phones and tablets. The deal between the two companies amounted to about 15% of Apple’s operating income. Its shares rose nearly 4% since Tuesday.

    “Apple also gets a nice win because the ruling forces Google to renegotiate the search deal annually,” Gene Munster, managing partner at Deepwater Asset Management, wrote on X.

    Critics of the remedies ruling were not surprised by Wall Street heralding Mehta’s decision as a win. “There’s a reason Google’s stock jumped after this ruling was released,” said Christo Wilson, a Northeastern University computer science professor who has conducted research on Google’s monopoly. “It is a historic misfire that fails to meet the enormity of the finding that Google is a monopolist in online search.”

    Continue Reading

  • One dose of antibiotic treats early syphilis as well as three doses 

    One dose of antibiotic treats early syphilis as well as three doses 

    Wednesday, September 3, 2025

    NIH-funded clinical trial shows potential to simplify treatment for early syphilis.

     Researchers funded by the National Institutes of Health (NIH) have found that a single injection of the antibiotic benzathine penicillin G (BPG) successfully treated early syphilis just as well as the three-injection regimen used by many clinicians in the United States and elsewhere. These findings from a late-stage clinical trial suggest the second and third doses of conventional BPG therapy do not provide a health benefit. The results were published today in The New England Journal of Medicine.

    “Benzathine penicillin G is highly effective against syphilis, but the three-dose regimen can be burdensome and deter people from attending follow-up visits with their healthcare providers,” said Carolyn Deal, Ph.D., chief of the enteric and sexually transmitted infections branch of NIH’s National Institute of Allergy and Infectious Diseases (NIAID). “The new findings offer welcome evidence for potentially simplifying treatment with an equally effective one-dose regimen, particularly while syphilis rates remain alarmingly high.”

    Syphilis is a common sexually transmitted infection (STI) caused by the bacterium Treponema pallidum. The United States reported 209,253 total syphilis cases and 3,882 congenital syphilis cases in 2023, representing 61% and 108% increases over 2019 numbers, respectively. Without treatment, syphilis can result in neurological and organ damage as well as severe pregnancy complications and congenital abnormalities. Syphilis can also increase a person’s likelihood of acquiring or transmitting HIV.

    BPG is one of the few antibiotics known to effectively treat syphilis, and stockouts are common worldwide. The antibiotic is currently being imported to the United States to resolve a nationwide shortage.

    The study was conducted at ten U.S. sites and enrolled 249 participants with early syphilis, which encompasses the primary, secondary, and early latent stages of disease. Sixty-four percent of participants were living with HIV and 97% were men. The participants were randomly assigned to receive either a single intramuscular (IM) injection of BPG 2.4 million units (MU) or a series of three IM injections of BPG 2.4 MU at weekly intervals. All participants were monitored for safety. Biological markers of successful treatment in the blood—known as the serologic response to therapy—were examined at six months following treatment.

    Seventy-six percent of participants in the single-dose group had a serologic response to treatment compared to 70% of participants in the three-dose group. The difference between groups was not statistically significant, even when participants were stratified by HIV status. One participant developed signs of neurosyphilis three days after starting BPG therapy and was excluded from the analysis. Three serious adverse events were reported but were not related to BPG.

    “Syphilis has been studied and treated for more than a century, and BPG has been in use for more than 50 years, yet we are still acquiring knowledge to help us optimize treatment,” said Principal Investigator Edward W. Hook III, M.D., emeritus professor of medicine and epidemiology at the University of Alabama at Birmingham. “We hope these promising results will be complemented by scientific advances in syphilis prevention and diagnosis.”

    According to the study authors, the results from this trial provide substantial evidence that single-dose BPG 2.4 MU is as effective as three doses in treating early syphilis. More research is needed to understand the full potential of this abbreviated treatment strategy and to evaluate therapeutic approaches for all stages of syphilis, including late syphilis, latent syphilis of unknown duration, and clinical neurosyphilis.

    The study was conducted through the NIAID-funded Sexually Transmitted Infections Clinical Trials Group.

    For more information about this trial, please visit ClinicalTrials.gov using the study identifier  NCT03637660.

    NIAID conducts and supports research—at NIH, throughout the United States, and worldwide—to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID website.

    About the National Institutes of Health (NIH): NIH, the nation’s medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.

    NIH…Turning Discovery Into Health®

    Continue Reading

  • Impact of GLP-1 Drug Adoption on Consumer Food Demand

    Impact of GLP-1 Drug Adoption on Consumer Food Demand

    GLP-1 weight loss drugs are likely to impact long-term category growth rates for food consumption.

    Their main mechanism of action is to make users feel satiated more quickly, reducing overall food intake as well as consumption of alcohol and tobacco. 

    Users report a 30 percent reduction in calories consumed. Adoption of these drugs is rising rapidly. FTI Consulting’s survey shows that more than 20 percent of US adults have used them in the past 12 months, despite high costs, side effects and the need for injectable delivery.

    As insurance coverage expands and out-of-pocket costs fall, use of GLP-1 drugs is likely to increase further, especially for weight loss. A reduction in pricing as production costs fall is expected to support adoption among lower-income groups. The potential launch of oral versions of the underlying molecule, expected around 2027–28, represents another catalyst that could broaden penetration into the US population.

    Line graph tracking GLP-1 adoption for weight loss and diabetes control from April 2023 to August 2024.

    Our analysis indicates that between 20 and 30 percent of annual patients stop using the drugs, particularly those focused on weight loss, and these patients regain about two-thirds of the weight they lost.

    The rise in GLP-1 adoption is creating important shifts in consumer behavior.

    Traditional high-calorie snacking categories and center-store products are seeing reduced consumption, slowing growth for portfolios heavily indexed to these areas. At the same time, recent adopters who use GLP-1 drugs for weight loss show greater interest in healthier and better-for-you alternatives across snacking categories.

    Chart showing GLP-1 adopters’ income and age distribution by diabetes control and weight loss use cases.

    Companies, both established and new, would benefit from recognizing this trend and aligning their innovation pipelines with the needs of this expanding segment of the US adult population.

    Weight management and active nutrition products are also benefiting from a broader adoption of GLP-1 drugs, as they are perceived as better supplements.

    In addition, some frozen food and dairy categories are experimenting with GLP-1-friendly labels.

    The trend is also affecting food consumed away from home, with noticeable impacts across different day parts and restaurant concepts.

    Two bar graphs showing restaurant patronage and food consumption after taking GLP-1.

    Survey results show that most fast-casual dining brands have a comparable or higher share of GLP-1 users than the general population.

    Health-focused brands tend to outperform other quick-service restaurants, likely due to a higher proportion of weight-conscious users, and casual dining brands overall are attracting a greater share of GLP-1 users among their guests.

    Different ways FTI Consulting can help with product and brand portfolio assessments and impact.

    Continue Reading

  • Djokovic unsure if he’ll be fit enough to beat Alcaraz in US Open semi-finals | US Open Tennis 2025

    Djokovic unsure if he’ll be fit enough to beat Alcaraz in US Open semi-finals | US Open Tennis 2025

    Novak Djokovic has admitted he is unsure of how physically ready he will be for his US Open semi-final against Carlos Alcaraz but is determined to do all he can to give himself the best chance against the Spaniard when they face each other on Friday.

    Djokovic reached the last four late on Tuesday night with a tremendous 6-3, 7-5, 3-6, 6-4 win against the fourth seed Taylor Fritz. Although Djokovic found himself under constant pressure in his service games and at times was outplayed by his American opponent, he showed his peerless mental toughness by saving his best level for the most important moments as he eked out a victory in four sets.

    The win set up another meeting with Alcaraz, the second seed and French Open champion, who eased into the semi-finals with a straight-sets win over Jiri Lehecka.

    “It’s not going to get easier. I tell you that,” said Djokovic, smiling. “Look, I’m going to try to take one day at a time. Really take care of my body. Try to relax and recover. The next couple of days is really key for me to really get my body in shape and ready to battle five sets if it’s needed. I just would really love that. Would love to be fit enough to play and to play potentially five sets with Carlos. I know that my best tennis is going to be required, but I’d rise to the occasion.

    “Normally I like to play the big matches on a big stage. It’s just that I’m not really sure how the body is going to feel in the next few days.

    “ But I’m going to do my very best with my team to be fit. There’s going to be a lot of running involved, that’s for sure. It’s not going to be short points.”

    At the age of 38 , Djokovic’s body has been a significant barrier to further success during an incredibly impressive season in which he has become the oldest man in the open era to reach the semi-finals of all four grand slam tournaments in a calendar year.

    Novak Djokovic had to call on the trainer during his defeat by Jannik Sinner in straight sets in the Wimbledon semi-finals. Photograph: Fred Mullane/ISI Photos/Getty Images

    The Serb has struggled physically towards the end of each of his runs this year. At the Australian Open he was forced to retire from his semi-final match against Alexander Zverev because of injury and then he was clearly struggling throughout his straight-sets loss at Wimbledon to Jannik Sinner.

    On this occasion, Djokovic will at least have two days to recover before the semi-final. On Wednesday, while Alcaraz worked through a light, leisurely practice at around midday with his brother, Alvaro, as his hitting partner, Djokovic opted against taking the long trip to Flushing as he prioritised recovery over the benefits of another day on site.

    “The good thing about the schedule is I have two days without a match, so that helps a lot,” he said. “I don’t feel very fresh at the moment, but hopefully in two days it will be different.”

    With his win over Fritz, Djokovic has now registered three top five wins at the grand slam tournaments this year alone, also beating the No 3 Zverev at Roland Garros, and Alcaraz himself at the Australian Open, when the Spaniard was also ranked No 3, an immense achievement that underlines his status as the third best player in the world. Alcaraz, however, is now playing some of the best tennis of his career and he will be attempting to reach his third consecutive grand slam final and seventh grand slam final overall.

    After his defeat, Fritz noted that Djokovic will probably relish the challenge of facing Alcaraz and then potentially Sinner as he tries to win his record-extending 25th grand slam singles title.

    “I think it just depends how much this one took out of him,” Fritz said. “I really can’t speak for him. I’m not sure. But, I mean, I was really excited at the fact. I was looking at the draw like: ‘Oh, I will have the opportunity to do the coolest thing ever, play Novak, potentially try to go through Novak, Carlos and Sinner.’ I liked the challenge. I’m sure he – being the competitor he is – is very excited for that challenge.”

    Continue Reading

  • UCIe, Marvell Memory And Rapidus 2nm Fab At The Hot Chips Conference

    UCIe, Marvell Memory And Rapidus 2nm Fab At The Hot Chips Conference

    I attended the IEEE Hot Chips Conference at Stanford and I wanted to share some of the interesting developments related to digital storage and memory technologies and other interesting developments. These include several talks that showed UCIe chiplet interconnect implementations, SRAM and DRAM improvements from Marvell and Rapidus’s success with their 2nm semiconductor fab.

    The open chiplet interconnect standard, UCIe was implemented on several chips that were showing at Hot Chips. Here are a few examples. The image below is a slide from a AyarLabs optical I/O chiplet.

    At a Korean-based AI company, Rebellions’ exhibit at Hot Chips they were showing a UCIe-based AI chiplet as shown below.

    Lightmatter spoke about a 3D interposer which enables an ASIC built with UCIe IP and laser communication as shown in the image below.

    Celestial AI was showing an SoC combining in-die optical I/O with electrical interconnects, including UCIe as shown below.

    UC Berkeley has been training students on taping out class chips using Chipyard as part of their education, resulting in real chip results. Students report that this is one of their most intense and fun classes at the University and it attracts more than just engineering students. As the slide below shows UCIe and other open source technologies are used in making these chips.

    Mark Kuemerle, VP of Technology at Marvell gave a talk on what they called a revolution in memory architecture for the data center. In particular the Marvell talk focused on a method for increasing the capacity and bandwidth of static random-access memory, SRAM. Marvell has a 2nm SRAM platform manufactured at TSMC.

    The company has made innovations in write assist, stability assist, pioneering high-sigma design modeling to capture tail bits and row plus column redundancy to enable low voltages and high overall yields. As a consequence Marvell’s custom SRAM achieves significant advantages over HBM and other embedded IP memory as shown below.

    Marvell said they achieve this by running faster and with more ports. The company also discussed its custom HBM architectures using IO chiplets with the companies D2D chiplet interconnect. The company announced at Hot Chips a 65 Gbps/wire Bi-Directional Die-to-Die interface IP in 2nm for the next generation of XPUs. They also showed their Structura A and X high capacity memories for near memory accelerators and memory expansion.

    Rapidus had a keynote talk on the last day where Rapidus CEO Atsuyoshi Kolke spoke about the building and initial operation of the company’s 2nm semiconductor fab on the Island of Hokkaido in Japan. In April the company had their first EUV test, shown below.

    Hot Chips showed UCIe chiplet interconnects, Marvell’s custom SRAM and HBM developments and Rapidus details on their 2nm semiconductor fab.

    Continue Reading

  • Wi-Fi signals can measure heart rate, no wearable device needed

    Wi-Fi signals can measure heart rate, no wearable device needed

    Your heartbeat is one of the simplest signals your body gives off, but it reveals a lot about your health. It changes with your activity, stress, and even how hydrated you are.

    Until recently, though, monitoring your heartrate meant using special devices like hospital monitors or smartwatches.


    But now, researchers at the University of California, Santa Cruz (UCSC), have shown that something as common as Wi-Fi can measure this vital sign with surprising accuracy.

    The new system, called Pulse-Fi, transforms ordinary wireless signals into health trackers.

    It promises a future where people can monitor their heart health without strapping on devices or relying on costly hospital machinery – all of this can be achieved using Wi-Fi devices that already exist in most homes.

    Understanding Wi-Fi – the basics

    Wi-Fi works by sending information through the air using radio waves, the same type of waves that carry music to your car radio. The difference is that Wi-Fi uses much higher frequencies, which lets it carry far more data.

    Inside your router, a tiny transmitter turns digital information – like a video or a message – into patterns of radio waves.

    Your phone or laptop has an antenna and receiver that catch those waves and turn them back into the pictures, sounds, or words you see on your screen.

    It’s like tossing a ball back and forth, but instead of a ball, the “catch” is a stream of invisible energy carrying coded information.

    Those radio waves don’t travel forever, though. Walls, floors, and even water in the human body can block or weaken them, which is the basic premise behind Pulse-Fi.

    Turning Wi-Fi into Pulse-Fi

    The UC Santa Cruz team included Professor Katia Obraczka, Ph.D. student Nayan Bhatia, and visiting high school researcher Pranay Kocheta.

    Together, they created a low-cost method that pairs Wi-Fi transmitters and receivers with machine learning algorithms.

    Wi-Fi waves move through space, bouncing and bending around objects. When those waves encounter the human body, tiny signal shifts occur.

    Pulse-Fi’s algorithms analyze those faint disturbances to pick out the rhythm of a heartbeat while filtering out unrelated movements or environmental noise.

    “The signal is very sensitive to the environment, so we have to select the right filters to remove all the unnecessary noise,” Bhatia said.

    Heartbeats measured in seconds

    The study involved 118 participants, and the results were impressive. After only five seconds of analysis,

    Pulse-Fi measured heartrate with an error margin of just half a beat per minute. Longer monitoring improved accuracy even further.

    The researchers tested people in varied body positions – sitting, standing, lying down, and even walking.

    Regardless of position, the system worked reliably. Hardware placement in the room also made little difference, proving the system’s adaptability.

    Low-cost components powered the tests. ESP32 chips, which cost under ten dollars, performed well.

    Raspberry Pi devices, though more expensive, achieved even better results. Commercial-grade Wi-Fi hardware could improve performance further.

    Distance doesn’t break accuracy

    Another breakthrough was range. Pulse-Fi measured heart rate accurately at distances up to three meters, or nearly ten feet. Additional tests suggest it can perform even farther.

    “What we found was that because of the machine learning model, that distance apart basically had no effect on performance, which was a very big struggle for past models,” Kocheta said.

    “The other thing was position – all the different things you encounter in day to day life, we wanted to make sure we were robust to however a person is living.”

    Creating Pulse-Fi datasets

    To train their system, the team needed data. No existing dataset captured heartbeat effects on Wi-Fi signals from ESP32 devices, so they built their own. In the UC Santa Cruz Science and Engineering Library, they carefully set up ESP32 units alongside standard oximeters to generate parallel data streams.

    This pairing provided a dependable “ground truth” for training, ensuring that every pulse recorded through Wi-Fi could be accurately matched with the medically verified heart rate.

    They then trained a neural network to recognize which subtle signal changes represented heartbeats, focusing on even the faintest variations in the wireless data.

    Alongside their newly built dataset, they validated Pulse-Fi using a large dataset from Brazil collected with Raspberry Pi hardware – one of the most comprehensive Wi-Fi-based health monitoring datasets available.

    That cross-testing confirmed the system’s broad reliability and showed that Pulse-Fi could adapt across device types, room conditions, and participant groups. It demonstrated that a low-cost approach could achieve remarkable accuracy under diverse real-world scenarios.

    Wi-Fi as health guardian

    Pulse-Fi’s creators are not stopping here. They are now adapting the system to detect breathing rates. Early results show strong potential for diagnosing issues like sleep apnea, where subtle breathing patterns are crucial for detection.

    Such a capability could give doctors new insights into sleep quality, respiratory problems, and long-term health risks – without the need for intrusive overnight monitoring.

    By combining affordability, accuracy, and non-intrusiveness, Pulse-Fi points to a future where everyday Wi-Fi doubles as a quiet guardian of health.

    Smart homes could eventually integrate the system, providing continuous tracking of both heart and lung function.

    This advancement would make preventive care more accessible, offering people the chance to detect health issues early and share reliable data with clinicians.

    What once required specialized devices might soon be handled by the invisible signals already surrounding us.

    The study is published in the journal IEEE Xplore.

    —–

    Like what you read? Subscribe to our newsletter for engaging articles, exclusive content, and the latest updates. 

    Check us out on EarthSnap, a free app brought to you by Eric Ralls and Earth.com.

    —–

    Continue Reading

  • See China’s new missiles, tanks and drones as it aims to rival U.S. – The Washington Post

    1. See China’s new missiles, tanks and drones as it aims to rival U.S.  The Washington Post
    2. Putin and Kim join Xi in show of strength as China unveils new weapons at huge military parade  BBC
    3. Analysis: China’s military display shows it has the might to back up Xi’s vision of a new world order  CNN
    4. Nuclear triad and ‘robot wolves’: parade shows off array of Chinese weapons  The Guardian
    5. Xi Jinping leads Beijing parade displaying China’s military power  Al Jazeera

    Continue Reading

  • Daniel Day-Lewis, Paul Mescal, Lynne Ramsay and George Clooney set for London film festival | London film festival

    Daniel Day-Lewis, Paul Mescal, Lynne Ramsay and George Clooney set for London film festival | London film festival

    As the curtain falls on the Venice and Telluride film festivals, and just before Toronto begins, the 69th London film festival has announced a programme that cherrypicks from all three predecessors.

    The annual public festival takes place in London but offers virtual and brick-and-mortar opportunities for people to watch from all over the UK.

    The third Knives Out film featuring Daniel Craig’s eccentric detective, Benoit Blanc, opens the festival, following its debut in Toronto later this week. Other key screenings include the European premiere of Chloé Zhao’s Hamnet, the Maggie O’Farrell adaptation which won raves for Jessie Buckley and Paul Mescal at its Telluride premiere last weekend, and the UK premieres of Hikari’s Rental Family, starring Brendan Fraser and Noah Baumbach’s meta comedy Jay Kelly, starring George Clooney.

    Bradley Cooper’s third film as director/star, standup comedy drama Is This Thing On? is also on the lineup, as is Bugonia, Yorgos Lanthimos’s well-received latest collaboration with Emma Stone.

    No less than 247 films are on the lineup this year from 79 countries, with 103 of them made by female or non-binary directors. This proportion – 42% – is marginally down on last year (44%), although there is parity in both the official competition selection and the debut film-makers sidebar.

    The latter category includes some high profile names, including Kristen Stewart, whose directorial debut The Chronology of Water stars Imogen Poots as an abuse survivor, as well as 27-year-old Ronan Day-Lewis, whose first feature, Anemone, was co-written by his father, Daniel, who also stars.

    The three time Oscar winner is the highest profile booking in the festival’s lineup of screen talks, which also includes Lanthimos, Jafar Panahi, Lynne Ramsay and Richard Linklater.

    The notoriously retiring star, who quit acting for the second time in 2017 before returning to make Anemone, is likely to be a hot ticket when he takes to the stage at the BFI Southbank to discuss his new film and career to date.

    “We really never thought that would happen,” said Kristy Matheson, director of the festival, of the booking. Although sworn to secrecy over Anemone, which has its first screening in New York in early October, Matheson said she believed audiences would be surprised by the film, which is set in the late 1980s and features Day-Lewis and Sean Bean as brothers who served as soldiers in Northern Ireland 20 years before, alongside co-star Samantha Morton.

    “It’s a really exciting debut because you’ve got these great actors – a really exceptional cast – but it doesn’t get them to do all the heavy lifting. It’s bold and it takes some really big swings stylistically.”

    Matheson notes that this year’s crop of movies also demonstrate an appetite among film-makers to play with the form.

    “There are so many films that seem to really be kind of stretching the language of cinema. It’s a medium that allows us to sort of play with time and space and so many directors are doing that.”

    She points particularly to the roster of urgent political films on this year’s slate, including Jafar Panahi’s Palme d’Or winner It Was Just an Accident, about corruption and paranoia in Iran, and fellow Cannes winner The Secret Agent by Kleber Mendonça Filho, set during the Brazilian military dictatorship – “a classically made film, but with so many playful interventions”.

    Also on the programme are The Voice of Hind Rajab, Kaouther Ben Hania’s dramatisation of the 2024 IDF killing of a five-year-old Palestinian girl who lived in the Gaza Strip and Sirāt, Óliver Laxe’s Moroccan desert thriller.

    But Matheson remains sceptical that film-makers have pulled up their collective socks as an emergency response service amid widespread global unrest.

    “Often films that seem topical have been in the making for many years. And sometimes, it’s just that the dial hasn’t really moved.” Matheson cites Landmarks, Lucrecia Martel’s documentary about the murder of Indigenous leader Javier Chocobar and the legacy of colonialism on Latin America.

    “That’s a very specific case, but she uses it to really look at the effects of colonisation on her country, and you can expand out further from that and think about the effects of colonisation on many different places. So it feels a really timely concept.”

    The Argentine director has, like Day-Lewis, been out of the spotlight for some years: her last feature was 2017’s Zama, which was made nine years after 2008’s The Headless Woman, regularly cited as one of the best films of the century so far.

    Her return, alongside that of Zhao, Ramsay and Kelly Reichardt (with The Mastermind), gives Matheson cheer, she says, in the face of otherwise disappointing statistics. “A 42% proportion [of non-male directors on the programme] is certainly not a number about which we would say, oh, isn’t this great. But these are major female directors with incredibly strong films.”

    World premieres at the festival include a drama about the friendship between Kate Moss and Lucian Freud and boxing drama Giant, starring Amir El-Masry and Pierce Brosnan.

    The London film festival runs between 8-19 October.

    Continue Reading

  • Meta Launches Instagram for iPad, Android Version Coming Soon

    Meta Launches Instagram for iPad, Android Version Coming Soon

    Instagram has launched a version of its app that is optimized for Apple’s iPad and that device’s bigger screen.

    The new Instagram for iPad opens with Reels, the app’s short video format, because people use bigger screens like the iPad’s for “lean back entertainment,” the company said in a Wednesday (Sept. 3) blog post.

    The app also makes it easy for users to access Stories and messaging, according to the post.

    Instagram for iPad also features a “Following” tab that gives users a choice of ways to prioritize and see content from the accounts they follow, a layout that displays the tabs for messages and notifications, and the ability to expand comment while watching Reels, while keeping the Reel at its full size, per the post.

    “It’s the Instagram you love, now with more space to play,” the post said.

    Instagram for iPad is now rolling out globally and available on the App Store. A tablet design for Android devices is coming soon, according to the post.

    Reuters reported Wednesday that this is Instagram’s first dedicated iPad application and that the app’s iPad experience previously used a scaled-up iPhone version, which has long caused complaints about blurry visuals and missing features.

    The report added that Instagram’s focus on Reels in the new version of the app came at a time when it is increasingly competing with TikTok.

    Parent company Meta said in July that its family of apps — Instagram, Facebook, WhatsApp and Messenger — draws 3.48 billion people daily, up 6% year over year.

    The company also said in a July 31 earnings report that its new recommendation models lifted ad conversions 5% on Instagram, its better ranking system added 6% more time spent on Instagram, and its early “business AIs” on Instagram are finding product-market fit, especially for small merchants.

    In June, Meta said it was testing artificial intelligence-generated 3D photos on Instagram within the Meta Quest augmented reality/virtual reality headset as part of its long-term effort to make immersive computing mainstream.

    Reality Labs is teaming up with Instagram to make the moments you share a little more magical,” the company said when announcing this testing.


    Continue Reading

  • As the 50% tariff impasse continues, is retaliation an option for India?

    As the 50% tariff impasse continues, is retaliation an option for India?

    Nikhil InamdarBBC News, Mumbai

    Hindustan Times via Getty Images Members of Federation of Sadar Bazar Trades Association raise slogans with Donald Trump's photos during a protest against the recent tariffs in New Delhi, India. Hindustan Times via Getty Images

    Prolonged 50% tariffs could shave off as much as 0.8% of India’s GDP

    US President Donald Trump’s 50% tariffs on India came into effect on 27 August. So far, rather than retaliating, India has put forth a carefully orchestrated geopolitical response to signal its displeasure to the US.

    There’s been the much publicised attempt at a rapprochement with China, and striking images of Prime Minister Narendra Modi sharing a limousine ride with Russian President Vladimir Putin splashed across the media from the sidelines of a security forum meeting in Tianjin.

    Domestically, Modi has announced some help for struggling exporters and there are tax cuts on the anvil to mitigate the impact on exports.

    But Delhi finds itself in an unenviable spot. The tariff impasse with its largest trading partner has continued far longer than anticipated, trade negotiations with Washington have come to a halt and the already damaged ties are fraying further with daily admonishments from US officials.

    The repercussions are significant.

    Prolonged 50% tariffs could shave off as much as 0.8% of India’s GDP, according to some estimates.

    India’s exports to the US could drop by as much as $35bn (£26.1bn) this financial year and put hundreds of thousands of jobs across key industries like textiles, gems and jewellery and leather at risk.

    Pushed to the brink, the question some are asking is whether Delhi will retaliate? And if not, what are its least damaging options?

    AFP via Getty Images Indian Prime Minister Narendra Modi talks with Russian President Vladimir Putin (L) and Chinese President Xi jinping (R) ahead of the Shanghai Cooperation Organisation (SCO) Summit 2025 in Tianjin, China. AFP via Getty Images

    India-China ties are seeing a thaw after years of tensions

    If the past is any precedent, India hasn’t shied away from retaliation. It imposed steep tariffs on some 28 US products, including almonds and apples back in 2019, when Washington had refused to exempt the country from higher taxes on steel and aluminium.

    But this time, escalating the trade war will not be in India’s interests, say experts.

    “Retaliation is a very costly and unproductive strategy because at the end of the day India depends more on the United States than is the case in reverse,” Ashley Tellis, a professor at the Carnegie Endowment for International Peace, told The Wire portal in an interview.

    At $86bn, India’s goods exports to the US are nearly three times higher than the US’s goods exports to India.

    India’s symbolic responses “in support of a multipolar world” including deepening engagement with Japan, China and Russia have been wise moves, Ajay Srivastava of the Delhi-based Global Trade Research Initiative told the BBC, adding that direct retaliation at this stage would be premature.

    “India should wait at least six months to assess the full extent of US actions—not just the 50% tariffs but also any additional measures that may follow, given the unpredictability of Trump and his advisers,” Srivastava said.

    Delhi needn’t look further than towards its bigger neighbour north to understand what tit-for-tat trade measures can potentially do. Tariffs on China went up to some 150% when Beijing slapped retaliatory duties.

    India should also be wary, some experts say, of the US expanding tariffs to non-goods areas like services, digital trade and outsourcing in the event of an escalation. These make up 6% of India’s GDP.

    US Commerce Secretary Howard Lutnick has already warned of changes to H1B non-immigrant visas, 70% of which are used up by Indians, indicating that the impact of tense geopolitical ties has transcended trade.

    AFP via Getty Images A garment worker sorts tailored shirts at an apparel manufacturing unit in Bengaluru on August 25, 2025. AFP via Getty Images

    India’s exports to the US could drop by as much as $35bn this financial year

    So given the risks of retaliating are clearly very high, what are India’s next best options?

    The best buffer against the risk of US tariffs will be diversifying export markets, say experts.

    It is time for India to “cultivate economic and diplomatic ties with countries like Mexico, Canada, and China. This also means strengthening trade and cooperation with other governments concerned about the impact of Trump’s tariffs, particularly in Europe and Latin America”, Kaushik Basu, former chief economic adviser to the Government of India, wrote in a recent piece for Project Syndicate.

    Srivastava agrees. Using diplomatic coalitions, and trade diversification is India’s best bet to “build pressure” on Washington, he says, keeping the option of targeted retaliation only as a measure of last resort.

    There are some indications already that Delhi has been actively working to expedite other trade pacts.

    After signing a comprehensive agreement with the UK in July, Indian Commerce Minister Piyush Goyal said the India-EU free trade deal was in advanced stages of negotiation.

    But diversification will not be a quick fix.

    “For an individual exporter, it is going to be much harder to find new customers in markets where they have previously not had partnerships, customers, or relationships,” Srividya Jandhyala, a Singapore based trade expert, told the BBC.

    Another challenge for Indian exporters will be the costs of switching to new markets.

    “If new clients or customers need specialised product lines, machinery, equipment, or components, Indian exporters have to decide if it is worth it for them to invest in this when there is a high degree of uncertainty about future tariffs” Jandhyala said.

    In the longer run though, there will be no option to find new trading partners given the mercurial nature of Trump’s policies, say experts.

    Mr Srivastava says the government must accelerate market diversification on a war-footing by doing things like leading sector-specific trade missions to alternative markets and establishing export hubs in countries like the UAE and Mexico to bypass high US tariffs.

    And now more than ever, “domestic competitiveness needs urgent strengthening through technology and quality upgradation funds” for exporters, he says.

    Otherwise India will further cede exports market share to other Asian peers like Bangladesh and Vietnam, who currently enjoy relatively better terms of trade with the US.

    Follow BBC News India on Instagram, YouTube, X and Facebook.


    Continue Reading